Literature DB >> 31656840

Data of small peptides in SMILES and three-dimensional formats for virtual screening campaigns.

Vivitri Dewi Prasasty1, Enade Perdana Istyastono2.   

Abstract

The data presented in this article are structures of dipeptides, tripeptides and tetrapeptides constructed from all possible combinations of 20 natural and common amino acids. In total, the data contains 168400 peptides. The structures are available in their simplified molecular-input line-entry system (SMILES) and three-dimensional (3D) formats. The type of data are text files, which could be accessed and modified either by text editor applications (e.g. Notepad++) or by molecule visualization softwares (e.g., YASARA View). These structures could be used further in virtual screening campaigns in the early stage of drug discovery projects.
© 2019 The Author(s).

Entities:  

Keywords:  Dipeptide; Drug discovery; Small peptide; Tetrapeptide; Tripeptide; Virtual screening

Year:  2019        PMID: 31656840      PMCID: PMC6806445          DOI: 10.1016/j.dib.2019.104607

Source DB:  PubMed          Journal:  Data Brief        ISSN: 2352-3409


Specifications Table The data provide structures of all possible natural dipeptides, tripeptides and tetrapeptides to be employed further in virtual screening campaigns. The SMILES formats of the peptides provide opportunities to perform virtual screening campaigns from the very beginning starting point. The 3D structures in mol2 formats provide opportunities to perform virtual screening campaigns from the 3D structure as the starting point. Since most of the peptides have molecular weight of less than 500 Da, the resulted hits in the virtual screening campaigns could be optimized further to be potential ligands in drug discovery projects.

Data

There are three files in the data: dipeptides.zip, tripeptides.zip, and tetrapeptides.zip. Each file contains two subdirectories, i.e., 3d-in-mol2 and smi. The directories 3d-in-mol2 and smi contain structures in 3D in mol2 format and structures in SMILES format, respectively. For dipeptides.zip and tripeptides, those directories contain structure files of the peptides named by their sequences in one-letter-code. These dipeptides and tripeptides have been subjected in a structure-based virtual screening to discover novel acetylcholinesterase (AChE) inhibitors [1] by employing a retrospectively validated protocol [2]. In tetrateptides.zip, the 3d-in-mol2 and smi directories contain subdirectories named with the first sequence of the peptides inside the directory followed by triple x. For example, Fig. 1 shows tripeptide EPI in the smi and the mol2 formats visualized using both Notepad++ as a text editor and Yasara View as a molecule visualization application. The file EPI.smi could be found in the subdirectory smi, while the file EPI.mol2 could be found in the subdirectory 3d-in-mol2 in tripeptides.zip.
Fig. 1

The EPI.smi in Notepad++ (A) and YASARA View (B), and the EPI.mol2 in Notepad++ (C) and YASARA View (D).

The EPI.smi in Notepad++ (A) and YASARA View (B), and the EPI.mol2 in Notepad++ (C) and YASARA View (D).

Experimental design, materials, and methods

The data were built in a computer server with Ubuntu Linux 14.04.5 as the operating system, 8GB RAM and 8 virtual CPUs of 6.4 GHz. First of all, three input files named dipeptides.lst, tripeptides.lst, and tetrapeptides.lst were made. These files contained all possible sequences of dipeptides, tripeptides, and tetrapeptides in their one-letter-code, respectively. Subsequently, the smi files were built by using module molconvert (Molecule File Converter, version 17.13.0) from ChemAxon (https://chemaxon.com/). Based on these smi files, the 3D structures were then built using module gen3d from Open Babel version 2.3.0 [3]. The molconvert module requires amino acids sequence to be converted to SMILES format. The following is, for example, the generic code to build the dipeptides presented in this article: for i in $(cat dipeptides.lst); do mkdir $i; cd $i; molconvert –peptide $i smiles > $i.smi; babel –title $i –gen3d -ismi $i.smi -omol2 $i.mol2; cd ..; done. The availability of the data will significantly reduce time to perform virtual screening campaigns. The following are some examples of study that could benefit from the data: (i) PeptoGrid - Rescoring function for AutoDock Vina to identify new bioactive molecules from short peptide libraries [4], (ii) Structure-based virtual screening for fragment-like ligands of the G protein-coupled histamine H4 receptor [5], and (iii) Natural peptides in drug discovery targeting acetylcholinesterase [1].

Specifications Table

Subject areaPharmaceutical Sciences
More specific subject areaDrug discovery
Type of dataText file
How data was acquiredMolecular modelling
Data formatRaw
Experimental factorsThe data were produced by employing a computer server with Ubuntu Linux 14.04.5 as the operating system, 8GB RAM and 8 virtual CPUs of 6.4 GHz
Experimental featuresThe data were built by employing two main computational chemistry tools, i.e., molconvert 17.13.0 from ChemAxon and gen3d from Open Babel version 2.3.0.
Data source locationData were built using molecular modelling techniques in a virtual laboratory owned by Sanata Dharma University, Yogyakarta, Indonesia.
Data accessibilityMendeley Data. doi:http://dx.doi.org/10.17632/z8zh5rpthg.1
Related research articlePrasasty, V. Radifar, M., Istyastono, E., 2018. Natural peptides in drug discovery targeting acetylcholinesterase. Molecules. 23(9): 2344.https://doi.org/10.3390/molecules23092344 [1]
Value of the Data

The data provide structures of all possible natural dipeptides, tripeptides and tetrapeptides to be employed further in virtual screening campaigns.

The SMILES formats of the peptides provide opportunities to perform virtual screening campaigns from the very beginning starting point.

The 3D structures in mol2 formats provide opportunities to perform virtual screening campaigns from the 3D structure as the starting point.

Since most of the peptides have molecular weight of less than 500 Da, the resulted hits in the virtual screening campaigns could be optimized further to be potential ligands in drug discovery projects.

  2 in total

Review 1.  Natural Peptides in Drug Discovery Targeting Acetylcholinesterase.

Authors:  Vivitri Prasasty; Muhammad Radifar; Enade Istyastono
Journal:  Molecules       Date:  2018-09-13       Impact factor: 4.411

2.  PeptoGrid-Rescoring Function for AutoDock Vina to Identify New Bioactive Molecules from Short Peptide Libraries.

Authors:  Arthur O Zalevsky; Alexander S Zlobin; Vasilina R Gedzun; Roman V Reshetnikov; Maxim L Lovat; Anton V Malyshev; Igor I Doronin; Gennady A Babkin; Andrey V Golovin
Journal:  Molecules       Date:  2019-01-13       Impact factor: 4.411

  2 in total
  4 in total

1.  Seafood Paramyosins as Sources of Anti-Angiotensin-Converting-Enzyme and Anti-Dipeptidyl-Peptidase Peptides after Gastrointestinal Digestion: A Cheminformatic Investigation.

Authors:  Tsun-Thai Chai; Clara Chia-Ci Wong; Mohamad Zulkeflee Sabri; Fai-Chu Wong
Journal:  Molecules       Date:  2022-06-16       Impact factor: 4.927

2.  A new ChEMBL dataset for the similarity-based target fishing engine FastTargetPred: Annotation of an exhaustive list of linear tetrapeptides.

Authors:  Shivalika Tanwar; Patrick Auberger; Germain Gillet; Mario DiPaola; Katya Tsaioun; Bruno O Villoutreix
Journal:  Data Brief       Date:  2022-04-11

3.  PyPLIF HIPPOS and Receptor Ensemble Docking Increase the Prediction Accuracy of the Structure-Based Virtual Screening Protocol Targeting Acetylcholinesterase.

Authors:  Enade P Istyastono; Florentinus Dika Octa Riswanto; Nunung Yuniarti; Vivitri D Prasasty; Sudi Mungkasi
Journal:  Molecules       Date:  2022-09-02       Impact factor: 4.927

4.  Discovery of compounds with viscosity-reducing effects on biopharmaceutical formulations with monoclonal antibodies.

Authors:  Matic Proj; Mitja Zidar; Blaž Lebar; Nika Strašek; Goran Miličić; Aleš Žula; Stanislav Gobec
Journal:  Comput Struct Biotechnol J       Date:  2022-09-26       Impact factor: 6.155

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.